Malcolm Cunningham

Background

About Malcolm Cunningham

ChargePoint Technology are market leaders in the supply of containment and aseptic valves with integrated material handling equipment for the Global Pharmaceutical, Chemical, Food and other process based industries Our most important goals are to create lasting partnerships by providing high quality and reliable containment & aseptic products, coupled with outstanding customer service As a pioneer of split valve containment and aseptic technology our consultative approach will provide the right technological containment solution, as well as delivering the lowest cost of ownership benefits by maximizing yield, reliability, productivity and flexibility It is our people, commitment to quality and an extensive Research and Development programme that ensures we provide our customers with products, project delivery and customer service to a level that surpasses all expectation. This approach is delivered through the dedication and participation of every employee within the company The ChargePoint® containment valve was originally developed in conjunction with Glaxo Pharmaceuticals (now GlaxoSmithKline) in 1996. Previously known as Contained Transfer Coupling (CTC), the fundamental features of the containment valve are still retained in the design as it stands today The precision engineered, patented containment technology has now become a pharmaceutical industry standard for high containment batch transfers. The ChargePoint® containment valve is a common solution for aseptic & contained charging/filling or contained, discharging/dispensing of potent compounds from a wide variety of pharmaceutical and chemical process equipment: from reactors and isolators to mixing and tablet pressing equipment The ChargePoint® containment split valve design has now enabled it to be applied within other areas of the pharmaceutical production process, for example bulk formulations, aseptic processes or steam in place as well as other markets such as the Biotechology